173 related articles for article (PubMed ID: 8416256)
1. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.
Benner SE; Winn RJ; Lippman SM; Poland J; Hansen KS; Luna MA; Hong WK
J Natl Cancer Inst; 1993 Jan; 85(1):44-7. PubMed ID: 8416256
[TBL] [Abstract][Full Text] [Related]
2. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia.
Benner SE; Wargovich MJ; Lippman SM; Fisher R; Velasco M; Winn RJ; Hong WK
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):73-6. PubMed ID: 8118389
[TBL] [Abstract][Full Text] [Related]
3. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract.
Papadimitrakopoulou VA; Clayman GL; Shin DM; Myers JN; Gillenwater AM; Goepfert H; El-Naggar AK; Lewin JS; Lippman SM; Hong WK
Arch Otolaryngol Head Neck Surg; 1999 Oct; 125(10):1083-9. PubMed ID: 10522499
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment.
Sankaranarayanan R; Mathew B; Varghese C; Sudhakaran PR; Menon V; Jayadeep A; Nair MK; Mathews C; Mahalingam TR; Balaram P; Nair PP
Oral Oncol; 1997 Jul; 33(4):231-6. PubMed ID: 9307711
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia.
Garewal H
Eur J Cancer Prev; 1994 Mar; 3(2):101-7. PubMed ID: 8019381
[TBL] [Abstract][Full Text] [Related]
6. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia.
Kaugars GE; Silverman S; Lovas JG; Brandt RB; Riley WT; Dao Q; Singh VN; Gallo J
Oral Surg Oral Med Oral Pathol; 1994 Oct; 78(4):462-8. PubMed ID: 7800378
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity.
Dimery IW; Hong WK; Lee JJ; Guillory-Perez C; Pham F; Fritsche HA; Lippman SM
Ann Oncol; 1997 Jan; 8(1):85-9. PubMed ID: 9093712
[TBL] [Abstract][Full Text] [Related]
8. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
[TBL] [Abstract][Full Text] [Related]
9. [Current status and prospects of chemoprevention in oral squamous epithelial carcinomas and precancerous lesions].
Zöller JE; Scheer M
Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S160-8. PubMed ID: 10938656
[TBL] [Abstract][Full Text] [Related]
10. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of oral cancer in leukoplakia patients: A systematic review and meta-analysis.
Xie A; Liu J
J Pak Med Assoc; 2017 Sep; 67(9):1415-1419. PubMed ID: 28924285
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention as a form of cancer control.
Toth BB; Martin JW; Lippman SM; Hong WK
J Am Dent Assoc; 1993 Jul; 124(7):243-6. PubMed ID: 8335795
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of a mixture of beta-carotene, alpha-tocopherol, glutathione, and ascorbic acid for cancer prevention.
Shklar G; Schwartz J; Trickler D; Cheverie SR
Nutr Cancer; 1993; 20(2):145-51. PubMed ID: 8233980
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of oral squamous cell carcinomas.
Scheer M; Kuebler AC; Zöller JE
Onkologie; 2004 Apr; 27(2):187-93. PubMed ID: 15138354
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of oral cancer: the need for effective biological monitoring.
Pillai MR; Ravi D; Nair MK
Singapore Dent J; 1997 Aug; 22(1):6-12. PubMed ID: 10597170
[TBL] [Abstract][Full Text] [Related]
17. Predicting cancer development in oral leukoplakia: ten years of translational research.
Lee JJ; Hong WK; Hittelman WN; Mao L; Lotan R; Shin DM; Benner SE; Xu XC; Lee JS; Papadimitrakopoulou VM; Geyer C; Perez C; Martin JW; El-Naggar AK; Lippman SM
Clin Cancer Res; 2000 May; 6(5):1702-10. PubMed ID: 10815888
[TBL] [Abstract][Full Text] [Related]
18. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
Armstrong WB; Kennedy AR; Wan XS; Taylor TH; Nguyen QA; Jensen J; Thompson W; Lagerberg W; Meyskens FL
Clin Cancer Res; 2000 Dec; 6(12):4684-91. PubMed ID: 11156220
[TBL] [Abstract][Full Text] [Related]
19. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
Meyskens FL
Ann N Y Acad Sci; 2001 Dec; 952():116-23. PubMed ID: 11795430
[TBL] [Abstract][Full Text] [Related]
20. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
Lippman SM; Benner SE; Hong WK
Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
